A Breakdown in Metabolic Reprogramming Causes Microglia Dysfunction in Alzheimer's Disease.

By Sung Hoon Baik, Seokjo Kang, Woochang Lee, Hayoung Choi, Sunwoo Chung, Jong-Il Kim, I. Mook-Jung. Cell Metabolism, 2019

688 citations recorded by the source corpus.

Reactive microglia are a major pathological feature of Alzheimer's disease (AD). However, the exact role of microglia in AD pathogenesis is still unclear. Here, using metabolic profiling, we found that exposure to amyloid-β triggers acute microglial inflammation accompanied by metabolic reprogramming from oxidative phosphorylation to glycolysis. It was dependent on the mTOR-HIF-1α pathway. However, once activated, microglia reached a chronic tolerant phase as a result of broad defects in energy metabolisms and subsequently diminished immune responses, including cytokine secretion and phagocytosis. Using genome-wide RNA sequencing and multiphoton microscopy techniques, we further identified metabolically defective microglia in 5XFAD mice, an AD mouse model. Finally, we showed that metabolic boosting with recombinant interferon-γ treatment reversed the defective glycolytic metabolism and inflammatory functions of microglia, thereby mitigating the AD pathology of 5XFAD mice. Collectively, metabolic reprogramming is crucial for microglial functions in AD, and modulating metabolism might be a new therapeutic strategy for AD.

Subfields: Immunology, Neurology, Physiology

View Paper: https://www.semanticscholar.org/paper/14d8cb0e4061f3c2b258638a8405adb118ed1661

How researchers see this paper

The researchers whose trusted networks rank it highest, strongest advocate first. Every researcher gets a different order.

In Immunology

  1. Chao Gao
  2. Shengdi Chen
  3. Yuyan Tan
  4. Jingwen Jiang

In Neurology

  1. Chao Gao
  2. Shengdi Chen
  3. Yuyan Tan
  4. Jingwen Jiang

Citations in the corpus